August 01, 2015 / Leukemia Cellular origin of prognostic chromosomal aberrations in AML patients H. Mora-Jensen J. Jendholm N. Rapin M.K. Andersen A.S. Roug F.O. Bagger L. Bullinger O. Winther N. Borregaard B.T. Porse K. Theilgaard-Mönch
April 01, 2016 / Clin Genet Mutations in SEC24D cause autosomal recessive osteogenesis imperfecta S. Moosa B.H.Y. Chung J.Y.L. Tung J. Altmüller H. Thiele P. Nürnberg C. Netzer G. Nishimura B. Wollnik
May 01, 2016 / Leukemia Impact of FLT3-ITD location on sensitivity to TKI-therapy in vitro and in vivo P. Arreba-Tutusaus T.S. Mack L. Bullinger T.M. Schnöder A. Polanetzki S. Weinert A. Ballaschk Z. Wang A.J. Deshpande S.A. Armstrong K. Döhner T. Fischer F.H. Heidel
February 01, 2024 / Haematologica Update and European consensus on a patient-centered core outcome set for multiple myeloma in clinical practice and research S. Oerlemans B.H. De Rooij C. Bennink L. Bullinger A. Broijl M. D'Agostino E. Laane M.T. Lupo-Stanghellini A. Perrot R. Wester V. Cursaru H. Scheurer J. Vesseur M. Dalal R. Sen T. Stamm H. Ludwig P. Sonneveld
July 01, 2016 / Bone Marrow Transplant Strong impact of extramedullary involvement in high-risk AML patients with active disease receiving the FLAMSA conditioning regimen for HSCT S. Bohl S. von Harsdorf M. Mulaw S. Hofmann A. Babiak C.P. Maier J. Schnell L.M. Hütter-Krönke K. Scholl V. Wais R.F. Schlenk L. Bullinger M. Ringhoffer H. Döhner D. Bunjes M. Bommer F. Kuchenbauer
January 25, 2024 / Neurol Res Pract Reevaluating the relevance of F-FDG PET findings for diagnosis of neurosarcoidosis: a case series J. Chen G. Metzger C. Furth G. Bohner V. Siffrin
November 01, 2016 / Leukemia Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group F. Theis A. Corbacioglu V.I. Gaidzik P. Paschka D. Weber L. Bullinger M. Heuser A. Ganser F. Thol B. Schlegelberger G. Göhring C.H. Köhne U. Germing P. Brossart H.A. Horst D. Haase K. Götze M. Ringhoffer W. Fiedler D. Nachbaur T. Kindler G. Held M. Lübbert M. Wattad H.R. Salih J. Krauter H. Döhner R.F. Schlenk K. Döhner
September 01, 2016 / Am J Med Genet A A novel homozygous PAM16 mutation in a patient with a milder phenotype and longer survival S. Moosa V. Fano M.G. Obregon J. Altmüller H. Thiele P. Nürnberg G. Nishimura B. Wollnik
November 01, 2016 / Haematologica MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses V. Shivarov A. Dolnik K.M. Lang J. Krönke F. Kuchenbauer P. Paschka V.I. Gaidzik H. Döhner R.F. Schlenk K. Döhner L. Bullinger
December 01, 2016 / Blood Cancer J MiR-139-5p is a potent tumor suppressor in adult acute myeloid leukemia K. Krowiorz J. Ruschmann C. Lai M. Ngom T. Maetzig V. Martins A. Scheffold E. Schneider N. Pochert C. Miller L. Palmqvist A. Staffas M. Mulaw S.R. Bohl C. Buske M. Heuser J. Kraus K. O'Neill C.L. Hansen O.I. Petriv H. Kestler H. Döhner L. Bullinger K. Döhner R.K. Humphries A. Rouhi F. Kuchenbauer